Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Deloitte
Mallinckrodt
Cipla
Federal Trade Commission
AstraZeneca
Merck
Boehringer Ingelheim
US Army
Dow

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020405

« Back to Dashboard
NDA 020405 describes LANOXIN, which is a drug marketed by Concordia Pharms Inc and Covis Pharma Bv and is included in two NDAs. It is available from twelve suppliers. Additional details are available on the LANOXIN profile page.

The generic ingredient in LANOXIN is digoxin. There are ten drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the digoxin profile page.

Summary for NDA: 020405

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020405

Ingredient-typeCardiac Glycosides

Suppliers and Packaging for NDA: 020405

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LANOXIN
digoxin
TABLET;ORAL 020405 NDA AUTHORIZED GENERIC NCS HealthCare of KY, Inc dba Vangard Labs 0615-7935 0615-7935-14 14 TABLET in 1 BLISTER PACK (0615-7935-14)
LANOXIN
digoxin
TABLET;ORAL 020405 NDA AUTHORIZED GENERIC NCS HealthCare of KY, Inc dba Vangard Labs 0615-7935 0615-7935-30 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-7935-30) > 5 TABLET in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.0625MG
Approval Date:Sep 30, 1997TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.125MG
Approval Date:Sep 30, 1997TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.1875MG
Approval Date:Sep 30, 1997TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Julphar
Deloitte
Moodys
Chinese Patent Office
QuintilesIMS
Medtronic
Cantor Fitzgerald
Novartis
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot